See more : Vista Group International Limited (VGL.NZ) Income Statement Analysis – Financial Results
Complete financial analysis of Control Bionics Limited (CBL.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Control Bionics Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- Dynavolt Renewable Energy Technology (Henan) Co., Ltd. (002684.SZ) Income Statement Analysis – Financial Results
- Hindprakash Industries Limited (HPIL.BO) Income Statement Analysis – Financial Results
- WiseTech Global Limited (WIGBY) Income Statement Analysis – Financial Results
- Xinjiang Joinworld Co.,Ltd. (600888.SS) Income Statement Analysis – Financial Results
- Aloro Mining Corp. (WLRMF) Income Statement Analysis – Financial Results
Control Bionics Limited (CBL.AX)
About Control Bionics Limited
Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia and North America. The company offers NeuroNode Trilogy and NeuroNode3 systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a device to control a range of devices, including wheelchairs, dining robots, and gaming systems; Uno Touch, a speech generating device; and other sensors for multiple applications. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Camberwell, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.13M | 5.44M | 4.38M | 3.93M | 3.10M | 781.45K | 805.42K | 323.70M | 248.31M | 0.00 |
| Cost of Revenue | 1.45M | 1.93M | 1.98M | 1.43M | 2.88M | 1.42M | 1.09M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 3.67M | 3.50M | 2.40M | 2.50M | 215.51K | -634.07K | -284.98K | 323.70M | 248.31M | 0.00 |
| Gross Profit Ratio | 71.64% | 64.48% | 54.85% | 63.60% | 6.95% | -81.14% | -35.38% | 100.00% | 100.00% | 0.00% |
| Research & Development | 1.71M | 230.99K | 328.88K | 166.23K | 68.30K | 361.23K | 79.04K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 5.67M | 5.29M | 4.91M | 3.33M | 786.34K | 137.88K | 71.81K | 31.54M | 20.51M | 0.00 |
| Selling & Marketing | 460.67K | 616.56K | 711.75K | 442.49K | 253.09K | 443.40K | 240.42K | 0.00 | 0.00 | 0.00 |
| SG&A | 6.13M | 5.91M | 5.62M | 3.77M | 1.35M | 1.06M | 694.29K | 31.54M | 20.51M | 0.00 |
| Other Expenses | 0.00 | 656.02K | 3.06M | 2.65M | 0.00 | 0.00 | 0.00 | 23.02M | 2.33M | 0.00 |
| Operating Expenses | 9.83M | 9.79M | 9.01M | 6.58M | 1.42M | 1.42M | 773.33K | 54.56M | 22.84M | 0.00 |
| Cost & Expenses | 11.28M | 11.72M | 10.99M | 8.01M | 4.30M | 2.83M | 1.86M | 279.58M | 198.77M | 0.00 |
| Interest Income | 12.18K | 20.14K | 1.33K | 1.16K | 1.23K | 5.06K | 1.84K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 56.28K | 12.31K | 8.89K | 32.78K | 3.33K | 436.00 | 1.16K | 13.91M | 6.30M | 0.00 |
| Depreciation & Amortization | 843.19K | 480.45K | 507.85K | 198.53K | 115.19K | 9.22K | 4.71K | 6.57M | 6.57M | 0.00 |
| EBITDA | -5.01M | -5.14M | -5.58M | -3.40M | -989.96K | -1.93M | -968.43K | 63.64M | 60.57M | 0.00 |
| EBITDA Ratio | -97.80% | -94.54% | -127.49% | -84.49% | -35.14% | -261.30% | -130.81% | 19.66% | 24.39% | 0.00% |
| Operating Income | -5.93M | -5.62M | -6.09M | -3.52M | -1.20M | -2.05M | -1.06M | 57.07M | 55.81M | 0.00 |
| Operating Income Ratio | -115.65% | -103.38% | -139.09% | -89.55% | -38.85% | -262.48% | -131.40% | 17.63% | 22.48% | 0.00% |
| Total Other Income/Expenses | 15.49K | -424.95K | -87.52K | -600.71K | 95.62K | 4.62K | 678.00 | -12.95M | -6.27M | 0.00 |
| Income Before Tax | -5.91M | -5.63M | -6.10M | -3.55M | -1.11M | -2.05M | -1.06M | 44.12M | 49.54M | 0.00 |
| Income Before Tax Ratio | -115.35% | -103.61% | -139.29% | -90.38% | -35.77% | -261.89% | -131.31% | 13.63% | 19.95% | 0.00% |
| Income Tax Expense | 0.00 | 668.33K | 8.89K | 636.85K | -102.98K | -114.87K | -85.17K | 13.41M | 14.03M | 0.00 |
| Net Income | -5.91M | -5.63M | -6.11M | -4.19M | -1.01M | -1.93M | -972.46K | 29.74M | 35.49M | 0.00 |
| Net Income Ratio | -115.35% | -103.61% | -139.49% | -106.59% | -32.44% | -247.19% | -120.74% | 9.19% | 14.29% | 0.00% |
| EPS | -0.04 | -0.06 | -0.06 | -0.05 | -0.01 | -0.02 | -0.01 | 0.13 | 0.21 | 0.00 |
| EPS Diluted | -0.04 | -0.06 | -0.06 | -0.05 | -0.01 | -0.02 | -0.01 | 0.13 | 0.21 | 0.00 |
| Weighted Avg Shares Out | 159.39M | 100.05M | 94.56M | 92.60M | 92.40M | 92.40M | 92.40M | 223.49M | 169.96M | 219.68M |
| Weighted Avg Shares Out (Dil) | 159.39M | 100.05M | 94.56M | 92.60M | 92.40M | 92.40M | 92.40M | 223.49M | 169.96M | 219.68M |
Source: https://incomestatements.info
Category: Stock Reports